BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
金曜日, 9 25

Apimeds Pharmaceuticals Us Inc

APUSAMEX
Trade with Public
Trade with Public
$6.43
1.5130.69%
最終更新: Sep 25, 12:36 PM
PRO
なぜ動いているのか？:Apimeds Pharmaceuticals shares are trading higher after the company announc...
概要ニュース業績予想財務センチメント株主構成比較株式レポート

Apimeds Pharmaceuticals Earnings & Forecasts

Apimeds Pharmaceuticals (APUS) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Apimeds Pharmaceuticals Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate————
Actual$-11.77$-22.60$-8.00$-14.00
Surprise————
Revenue
Estimate————
Actual$0$0$0$0
Surprise————

Earnings & Guidance News

PRO
Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 percent decrease over losses of $(0.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Apimeds Pharmaceuticals Q2 EPS $(0.26) Down From $(0.06) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.26) per share. This is a 333.33 percent decrease over losses of $(0.06) per share from the same period last year.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved